Annual Retained Earnings
-$321.11 M
-$106.31 M-49.49%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual retained earnings is -$321.11 million, with the most recent change of -$106.31 million (-49.49%) on December 31, 2022.
- During the last 3 years, IMPL annual retained earnings has fallen by -$228.65 million (-247.28%).
Performance
IMPL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$372.35 M
-$13.81 M-3.85%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly retained earnings is -$372.35 million, with the most recent change of -$13.81 million (-3.85%) on September 1, 2023.
- Over the past year, IMPL quarterly retained earnings has dropped by -$74.28 million (-24.92%).
Performance
IMPL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IMPL Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.5% | -24.9% |
| 3 y3 years | -247.3% | - |
| 5 y5 years | -247.3% | - |
IMPL Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +49.5% | at low | +73.3% | at low |
| 5 y | 5-year | +247.3% | at low | +169.3% | at low |
| alltime | all time | +247.3% | at low | +169.3% | at low |
Impel Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$372.35 M(+3.9%) |
| Jun 2023 | - | -$358.53 M(+2.1%) |
| Mar 2023 | - | -$351.18 M(+9.4%) |
| Dec 2022 | -$321.11 M | -$321.11 M(+7.7%) |
| Sep 2022 | - | -$298.07 M(+11.6%) |
| Jun 2022 | - | -$266.97 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$241.77 M(+12.6%) |
| Dec 2021 | -$214.80 M(+55.4%) | -$214.80 M(+13.0%) |
| Sep 2021 | - | -$190.06 M(+15.2%) |
| Jun 2021 | - | -$165.03 M(+10.4%) |
| Mar 2021 | - | -$149.55 M(+8.2%) |
| Dec 2020 | -$138.26 M(+49.5%) | -$138.26 M |
| Dec 2019 | -$92.46 M | - |
FAQ
- What is Impel Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual retained earnings year-on-year change?
- What is Impel Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly retained earnings year-on-year change?
What is Impel Pharmaceuticals annual retained earnings?
The current annual retained earnings of IMPL is -$321.11 M
What is the all time high annual retained earnings for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual retained earnings is -$92.46 M
What is Impel Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, IMPL annual retained earnings has changed by -$106.31 M (-49.49%)
What is Impel Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of IMPL is -$372.35 M
What is the all time high quarterly retained earnings for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly retained earnings is -$138.26 M
What is Impel Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, IMPL quarterly retained earnings has changed by -$74.28 M (-24.92%)